+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 0Months - 12Months
All Genders
ID06636955

Study of Respiratory Viruses in Infants Under 12 Months With First Bronchiolitis Episode After Nirsevimab Use

Led by University Hospital, Rouen · Updated on 2024-10-15

900

Participants Needed

1

Research Sites

64 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying acute bronchiolitis in infants, mainly caused by the Respiratory Syncytial Virus RSV, which is a significant health concern due to its impact on illness and hospital costs. This study aims to understand how the use of Nirsevimab, a long-acting antibody for infants under 12 months, affects the spread of RSV and other respiratory viruses during future epidemic seasons. The research focuses on viral patterns and the respiratory health evolution in infants over time. Infants aged 12 months or younger who experience their first episode of bronchiolitis and visit the pediatric emergency department will be included. Nasopharyngeal swabs will be taken as part of routine care to identify the viruses causing bronchiolitis using a multiplex Polymerase Chain Reaction test. Hospitalized infants testing positive for RSV or rhinovirus will have daily nasal washes collected for viral load measurement. Participants will be divided into groups based on whether they received passive immunization with Nirsevimab. Each infant will be followed for 12 months, with clinical data collected through four phone calls to track respiratory health and the onset of preschool wheezing. Researchers will monitor viral populations and clinical symptoms and evaluate the impact of respiratory infections on short and long-term health and economic factors. The main outcome measured is the prevalence of viruses identified in infants with and without Nirsevimab over three years.

CONDITIONS

Brief Title

Viral Epidemiology of Bronchiolitis After Nirsevimab Implementation and Respiratory Evolution in Infants

Research Team

H

Hortense PETAT, Doctor

C

Cécile Pourcher

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here